Amgen AMGN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.62B+5.8% | $9.87B+8.6% | $9.56B+12.4% | $9.18B+9.4% | $8.15B+9.4% | ||
| $2.74B-7.5% | $2.98B-4.4% | $3.08B-6.9% | $3.01B-7.0% | $2.97B-7.2% | ||
| $5.87B+13.4% | $6.89B+15.3% | $6.48B+24.7% | $6.17B+19.7% | $5.18B+22.0% | ||
| 68.2%+4.6pp | 69.8%+4.1pp | 67.8%+6.7pp | 67.2%+5.8pp | 63.6%+6.5pp | ||
| $1.72B+15.7% | $2.14B+24.2% | $1.9B+31.0% | $1.74B+20.5% | $1.49B+10.6% | ||
| $1.6B-5.0% | $1.95B+3.9% | $1.72B+5.8% | $1.69B-5.3% | $1.69B-6.7% | ||
| $1.12B-19.5% | $1.13B-19.0% | $1.31B-6.4% | $1.34B-4.2% | $1.39B-0.9% | ||
| $5.95B-14.6% | $7.15B+5.5% | $7.03B+8.9% | $6.52B+0.7% | $6.97B+8.0% | ||
| $2.67B+126% | $2.72B+17.7% | $2.53B+23.4% | $2.66B+39.1% | $1.18B+18.9% | ||
| 30.9%+16.5pp | 27.6%+2.1pp | 26.4%+2.4pp | 28.9%+6.2pp | 14.5%+1.1pp | ||
| $657M-9.1% | $653M-12.6% | $685M-11.7% | $694M-14.1% | $723M-12.3% | ||
| $75M-95.1% | —— | $2.08B+13.7% | -$394M-28.3% | $1.52B+746% | ||
| $2.08B+5.6% | $1.51B+93.6% | $3.92B+26.4% | $1.57B+97.5% | $1.97B+3,001% | ||
| $265M+9.1% | $181M+16.8% | $705M+160% | $136M+183% | $243M+440% | ||
| $1.82B+5.1% | $1.33B+113% | $3.22B+13.6% | $1.43B+92.0% | $1.73B+1,631% | ||
| 21.1%-0.1pp | 13.5%+6.6pp | 33.7%+0.4pp | 15.6%+6.7pp | 21.2%+22.7pp | ||
| $3.34+4.4% | $2.46+112% | $5.93+13.6% | $2.65+92.0% | $3.20+1,624% | ||
| $3.37+4.7% | $2.47+111% | $5.98+13.5% | $2.66+91.4% | $3.22+1,633% | ||
| 544M+0.6% | 542M+0.2% | 542M0.0% | 541M0.0% | 541M+0.9% | ||
| 540M+0.4% | 538M+0.2% | 538M+0.2% | 538M+0.2% | 538M+0.4% | ||
| $0-100% | —— | $400M+556% | —— | $800M+1,076% | ||
| $67M+34.0% | -$250M-758% | $28M— | $23M— | $50M-73.7% | ||
| -$143M-111% | —— | $1.97B+20.7% | —— | $1.3B+351% | ||
| -$176M+29.6% | -$19M+94.3% | -$30M+72.7% | -$422M-10.2% | -$250M+37.7% | ||
| $571M+14.9% | —— | —— | $589M-8.4% | $497M+2,061% | ||
| -$413M-132% | $1.08B+327% | $0-100% | $515M— | $1.31B+369% | ||
| $71M-31.7% | -$365M— | —— | -$2.42B-57.6% | $104M-53.4% | ||
| -$959M-9.7% | $749M+2.9% | -$200M+27.3% | $824M+18.9% | -$874M+17.1% | ||
| -$18M+93.8% | -$119M+63.2% | -$240M+64.8% | -$239M+66.9% | -$288M+64.3% | ||
| $71M+1.4% | $75M— | $74M— | $92M— | $70M+110% | ||
| -$8M-104% | $577M+4,021% | $283M-5.4% | $206M-17.6% | $201M+126% | ||
| -$75M+3.8% | -$76M— | -$10M+74.4% | $0— | -$78M-39.3% | ||
| -$839M-273% | —— | $1.18B+27.4% | $627M+914% | $486M+254% | ||
| $657M-9.1% | $653M-12.6% | $685M-11.7% | $694M-14.1% | $723M-12.3% | ||
| $1.44B+135% | -$1.23B+12.9% | -$2.85B+21.9% | -$2.67B-0.9% | -$4.11B-140% | ||
| -$716M-60.2% | -$693M-72.4% | -$414M-97.1% | -$389M-79.3% | -$447M-106% | ||
| $2.19B+57.4% | $1.6B-66.4% | $4.68B+31.2% | $2.28B-7.3% | $1.39B+102% | ||
| $67M+34.0% | -$250M-758% | $28M— | $23M— | $50M-73.7% | ||
| -$113M-114% | —— | —— | —— | $830M— | ||
| $4M-88.9% | —— | —— | $20M+195% | $36M+377% | ||
| $1.36B+6.2% | $1.28B+6.5% | $1.28B+6.0% | $1.28B+5.9% | $1.28B+5.9% | ||
| $712M+73.2% | $642M+73.0% | $436M+69.6% | $369M+55.0% | $411M+78.7% | ||
| $3.96B— | —— | —— | —— | $0— | ||
| -$104M-285% | —— | —— | -$92M-130% | -$27M+70.0% | ||
| $833M-66.7% | $0— | $1.5B-31.8% | $1B-28.6% | $2.5B— | ||
| $1.72B+15.7% | $2.14B+24.2% | $1.9B+31.0% | $1.74B+20.5% | $1.49B+10.6% | ||
| $8.62B+5.8% | $9.87B+8.6% | $9.56B+12.4% | $9.18B+9.4% | $8.15B+9.4% | ||
| $75M-11.8% | $125M-6.7% | $127M-6.6% | $157M0.0% | $85M-17.5% | ||
| $3.78B+47.4% | $3.85B+3.9% | $3.83B+11.3% | $4B+20.8% | $2.57B+7.3% | ||
| 43.9%+12.4pp | 39%-1.8pp | 40.1%-0.4pp | 43.5%+4.1pp | 31.5%-0.6pp | ||
| $2.67B+126% | $2.72B+17.7% | $2.53B+23.4% | $2.66B+39.1% | $1.18B+18.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Amgen's revenue?
- Amgen (AMGN) generated $37.2B in revenue over the trailing twelve months, up 9.1% year over year.
- Is Amgen profitable?
- Amgen reported $7.8B in net income over the trailing twelve months, a 21.0% net margin.
- What are Amgen's profit margins?
- Gross margin is 68.3% and operating margin is 28.4%, with a 21.0% net margin.
- What is Amgen's earnings per share?
- Amgen's diluted EPS over the trailing twelve months is $14.38.
- Where does Amgen's income statement data come from?
- Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
